{
    "title": "Biocon shares hit record high as cancer drug Pegfilgrastim gets USFDA nod",
    "link": "https://www.business-standard.com/article/markets/biocon-hits-record-high-as-cancer-drug-pegfilgrastim-get-usfda-nod-118060500190_1.html",
    "pubDate": "Tue, 05 Jun 2018 09:43:00 +0530",
    "content": "The stock hit a record high of Rs 695, up 6% on the BSE in opening deal in otherwise weak market.",
    "contentSnippet": "The stock hit a record high of Rs 695, up 6% on the BSE in opening deal in otherwise weak market.",
    "guid": "https://www.business-standard.com/article/markets/biocon-hits-record-high-as-cancer-drug-pegfilgrastim-get-usfda-nod-118060500190_1.html",
    "isoDate": "2018-06-05T04:13:00.000Z",
    "sentiment": {
        "score": 0,
        "comparative": 0,
        "tokens": [
            "biocon",
            "shares",
            "hit",
            "record",
            "high",
            "as",
            "cancer",
            "drug",
            "pegfilgrastim",
            "gets",
            "usfda",
            "nod"
        ],
        "words": [
            "cancer",
            "shares"
        ],
        "positive": [
            "shares"
        ],
        "negative": [
            "cancer"
        ]
    },
    "article": {},
    "adjectives": [
        "high",
        "stock",
        "opening",
        "otherwise",
        "weak"
    ],
    "verbs": [
        "hit",
        "record",
        "drug",
        "nod",
        "stock",
        "deal",
        "market"
    ],
    "nouns": [
        "hit",
        "record",
        "high",
        "cancer",
        "nod",
        "stock",
        "BSE",
        "opening",
        "deal",
        "market",
        "drug"
    ]
}